spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 18 Mar 2013
Labrys Biologics Announces Key Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2013
Spectrum Pharmaceuticals Appoints Lee F. Allen, M.D., Ph.D., Industry Veteran, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Mar 2013
Chimerix Appoints Michael D. Rogers, Ph.D., as Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Mar 2013
Spectrum Pharmaceuticals Gains Rights to Pivotal-Stage Captisol-Enabled(R) Melphalan
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Mar 2013
Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2013
Shire Acquires Premacure AB
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 12 Mar 2013
Boston Therapeutics Appoints Peter Sheehan, M.D. as Medical Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2013
Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies
Diagnostics Oncology
 HSMN NewsFeed - 11 Mar 2013
NovaBay Names Keith Bley as Senior Vice President of Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Mar 2013
Mobius Therapeutics(TM) Receives Payment Indicator for Reimbursement of Mitosol(R)
Biopharmaceuticals Ophthalmology Reimbursement
 HSMN NewsFeed - 11 Mar 2013
Moberg Derma Discontinues Clinical Development of Limtop
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 7 Mar 2013
PTC Therapeutics Closes $60 Million Private Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 7 Mar 2013
Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2013
United States Patent & Trademark Office Grants Pfizer Reissue Patent For Celebrex(R) (celecoxib capsules)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Mar 2013
Catalyst Pharmaceutical Partners Appoints Dr. Bernardino Mosquera as Vice President of Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Mar 2013
Intercept Pharmaceuticals Appoints Daniel Regan as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Mar 2013
Ironwood Pharmaceuticals Appoints Edward Owens to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Mar 2013
Clearside Biomedical, Inc. Names Stephen H. Lang Vice President, Commercial Operations
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 1 Mar 2013
Sucampo Appoints Barbara A. Munder and Maureen E. O’Connell to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Feb 2013
ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"
Biopharmaceuticals
 HSMN NewsFeed - 28 Feb 2013
FDA Grants QIDP and Fast Track Designations for Cubist’s Late-Stage Antibiotic Candidates
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Feb 2013
CSL Behring Receives FDA Approval to Expand the Indication for Corifact(R)
Biopharmaceuticals Surgery FDA
 HSMN NewsFeed - 28 Feb 2013
Pernix Therapeutics Receives FDA Approvals
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Feb 2013
A.P. Pharma Appoints Jesse Hollingsworth as Vice President of Sales
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 28 Feb 2013
Kala Pharmaceuticals Secures $11.5 Million in Series A Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 27 Feb 2013
Christel Bories Joins Ipsen as Deputy Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2013
Brickell Biotech Announces $7M Series B Financing to Fund Development of Novel Dermatology Treatments
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 26 Feb 2013
DecImmune Therapeutics Secures $2.25 Million in Development Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Feb 2013
Helix BioPharma Announces Director Resignation
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Feb 2013
Cubist Announces Exclusive Option to Acquire Adynxx
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Feb 2013
Actavis' Generic Suboxone(R) Receives FDA Approval
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Feb 2013
Clearside Biomedical, Inc. Names Rafael V. Andino Vice President, Product Development
Biopharmaceuticals Ophthalmology Drug Delivery Personnel
 HSMN NewsFeed - 25 Feb 2013
Dynavax Receives FDA Complete Response Letter on HEPLISAV(TM) Biologic License Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Feb 2013
Lupin Receives FDA Approval for New Drug Application for SUPRAX(R) Oral Suspension, 500 mg/5mL
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Feb 2013
Alexza Receives Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Feb 2013
Valeant Pharmaceuticals Acquires U.S. Rights to Targretin(R) from Eisai Inc.
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 21 Feb 2013
Top-Line Data Show Lyrica Met Primary Endpoint in Clinical Trial as Adjunctive Therapy versus Levetiracetam in Patients with Partial Onset Seizures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Feb 2013
Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection To Sandor Medicaids Pvt. Ltd. For Commercialization In India
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 21 Feb 2013
Gentium Provides Update on the Review of Defibrotide Marketing Authorization
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Feb 2013
ARIAD Announces Appointment of European General Manager and Other Key Members of Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Feb 2013
Ernest Mario, Ph.D., Named Chairman of Chimerix, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2013
Mobius Therapeutics(TM) Provides Update on Recall of Two Lots of Mitosol(R)
Biopharmaceuticals Ophthalmology Product Recall
 HSMN NewsFeed - 19 Feb 2013
MethylGene Announces the Appointment of Mark J. Gergen, as Executive Vice President and COO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2013
Curis Appoints Ali Fattaey, Ph.D. as President and Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Feb 2013
Regeneron and Bayer Initiate Phase 3 Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 18 Feb 2013
Roche and Chiasma Announce Collaboration to Develop and Commercialize Chiasma's Octreolin(R) for Acromegaly and Neuroendocrine Tumors
Biopharmaceuticals Endocrinology Licensing
 HSMN NewsFeed - 18 Feb 2013
Alchemia Appoints Charles Walker as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Feb 2013
Genzyme Announces Positive New Data from Two Phase 3 Studies for Oral Eliglustat Tartrate for Gaucher Disease
Biopharmaceuticals
 HSMN NewsFeed - 15 Feb 2013
Onyx Pharmaceuticals Appoints Dr. Pablo Cagnoni as Executive Vice President, Global Research & Development and Technical Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Feb 2013
Elcelyx Therapeutics Completes $20 Million Series C Financing to Advance NewMet and Lovidia
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 14 Feb 2013
Santarus Announces Commercial Launch of UCERIS (budesonide) Extended Release Tablets
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 14 Feb 2013
Verastem Files for Orphan Disease Status for VS-6063 in Mesothelioma
Biopharmaceuticals Oncology Regulatory FDA
 HSMN NewsFeed - 13 Feb 2013
Ritter Pharmaceuticals Names Larry Good, M.D. Chief Medical Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 13 Feb 2013
Cellerant Appoints William Reed, M.D., as Vice President, Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Feb 2013
Lpath Promotes Leigh Hsu, Ph.D., to Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Feb 2013
Kolltan Pharmaceuticals Expands Senior Management Team, Appoints Jane Henderson as Senior Vice President & Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Feb 2013
Sobi gains distribution rights for Megace(R), Monopril(R), Cefzil(R); and Duricef(R); from PharmaSwiss
Biopharmaceuticals Distribution
 HSMN NewsFeed - 12 Feb 2013
EpiCept Corporation and Immune Pharmaceuticals Amend Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Feb 2013
Ironwood Pharmaceuticals Promotes Dr. Mark Currie to Senior Vice President, Chief Scientific Officer, and President of R&D
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2013
Repros Therapeutics Corporate Update
Biopharmaceuticals FDA Personnel
 HSMN NewsFeed - 11 Feb 2013
Bayer Submits New Drug Application for Riociguat for the Treatment of Pulmonary Arterial Hypertension and Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 11 Feb 2013
Cardiorentis initiates first-ever acute heart failure Phase III clinical trial designed to assess early treatment on cardiovascular mortality and symptoms
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 8 Feb 2013
The Medicines Company and Bristol-Myers Squibb Begin Global Alliance for Recothrom(R)
Biopharmaceuticals Surgery Licensing Distribution
 HSMN NewsFeed - 8 Feb 2013
Impax and Shire Settle Litigation Concerning Supply of Authorized Generic Adderall XR(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Feb 2013
Tranzyme Pharma Announces Exploration of Strategic Alternatives
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Feb 2013
BioAegis Therapeutics Inc. Completes Initial $3 Million Raise
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Feb 2013
Amgen Outlines Long-Term Strategy
Biopharmaceuticals
 HSMN NewsFeed - 6 Feb 2013
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 6 Feb 2013
Biogen Idec to Acquire Full Rights and Control of TYSABRI(R) from Elan for Upfront Cash and Contingent Payments
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 5 Feb 2013
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Actavis
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Feb 2013
Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 5 Feb 2013
Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 5 Feb 2013
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna(TM) (imilecleucel-T) for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 5 Feb 2013
Orexo strengthens the commercial leadership structure and appoints Nikolaj Sørensen as new CEO and Martin Nicklasson as Executive Chairman
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 5 Feb 2013
ZALTRAP(R) (ziv-aflibercept) Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 4 Feb 2013
H. D. Smith Specialty Solutions Appoints 20-year Industry Veteran Tim Booth To Executive Vice President, Smith Medical Partners
Biopharmaceuticals Distribution Personnel
 HSMN NewsFeed - 1 Feb 2013
Pfizer Inc. Issues Statement on Zoetis(TM) IPO
Biopharmaceuticals
 HSMN NewsFeed - 1 Feb 2013
NeuroVive Appoints Chief Operating Officer
Biopharmaceuticals Cardiology Neurology Personnel
 HSMN NewsFeed - 31 Jan 2013
Aduro Announces $6.5 Million Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 31 Jan 2013
Pfizer Wins RAPAMUNE(R) Patent Case in Delaware District Court
Biopharmaceuticals Litigation
 HSMN NewsFeed - 31 Jan 2013
Spectrum Pharmaceuticals Acquires Rights for Apaziquone in the U.S., Europe and Other Territories from Allergan; Expects to File New Drug Application
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Jan 2013
Dyax Corp. and Novellus Biopharma AG Announce Partnership to Develop and Commercialize KALBITOR(R) (ecallantide) for Hereditary Angioedema (HAE) and Other Angioedema Indications in Latin America
Biopharmaceuticals Licensing
 HSMN NewsFeed - 30 Jan 2013
Mirna Therapeutics Inc. Appoints Clay B. Siegall, Ph.D., to Its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jan 2013
MEI Pharma Announces Retirement Of Chairman Bryan Williams From Board Of Directors And Appointment Of Christine White As Lead Director
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jan 2013
MyoKardia Appoints Industry Veteran Jonathan Fox, M.D., Ph.D., as Chief Medical Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 30 Jan 2013
PDL BioPharma Announces Departure of Finance VP
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2013
Bionor Pharma Appoints Anker Lundemose as President and Chief Executive Officer
Biopharmaceuticals HIV/AIDS Personnel
 HSMN NewsFeed - 29 Jan 2013
FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Jan 2013
New NCCN Guidelines for Patients(R) Available for Adolescents and Young Adults with Cancer
Biopharmaceuticals Devices Oncology
 HSMN NewsFeed - 28 Jan 2013
Results from Active Biotech's Phase II/III ANYARA trial for the treatment of renal cell cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jan 2013
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 25 Jan 2013
FDA Approves OXYTROL(R) FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women
Biopharmaceuticals Drug Delivery Urology FDA
 HSMN NewsFeed - 24 Jan 2013
Amarin Announces Market Introduction of Vascepa(R) (icosapent ethyl) Capsules for the Treatment of Very High Triglycerides (VHTG)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 24 Jan 2013
Baxter Announces Agreement to Acquire Investigational Hemophilia Compound OBI-1 and Related Assets
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 24 Jan 2013
Acorda Therapeutics Announces Department of Defense Contract to Support Study of AC105 in Acute Spinal Cord Injury
Biopharmaceuticals Neurology Neurosurgery
 HSMN NewsFeed - 23 Jan 2013
Watson Acquires Uteron Pharma SA
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Jan 2013
Allergan, Inc. to Acquire MAP Pharmaceuticals, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 22 Jan 2013
Verastem Promotes Chief Operating Officer Robert Forrester to President
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Jan 2013
Tau Therapeutics Hires Chief Medical Officer and VP of Operations and Strategy
Biopharmaceuticals Personnel
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!